STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 14, 2026, 07:32 AM

FitLife Brands Q1 Revenue +59% to $25.3M; Net Income $1.7M

AI Summary

FitLife Brands reported a 59% increase in total revenue to $25.3 million for the first quarter ended March 31, 2026, driven significantly by the acquisition of Irwin. Despite the revenue growth, net income decreased to $1.7 million from $2.0 million year-over-year, and basic EPS fell to $0.18 from $0.22, primarily due to higher amortization and interest expenses related to the acquisition. The company faced challenges including consumer weakness, Amazon algorithm changes, and supply chain issues at Irwin, but noted sequential monthly revenue improvements and new product launches, while continuing debt reduction efforts.

Key Highlights

  • Total revenue increased 59% to $25.3 million in Q1 2026 compared to Q1 2025.
  • Net income was $1.7 million, down from $2.0 million in Q1 2025.
  • Basic earnings per share was $0.18, down from $0.22 in Q1 2025.
  • Wholesale revenue grew 166% to $14.1 million, largely due to the Irwin acquisition.
  • Online revenue increased 6% to $11.2 million in Q1 2026.
  • Gross margin declined to 37.6% from 43.1% in Q1 2025, primarily due to Irwin acquisition.
  • Adjusted EBITDA decreased 3% to $3.3 million compared to Q1 2025.
  • The company reduced its term loan by $1.5 million and revolving line of credit by $1.4 million.
FTLF
Medicinal Chemicals and Botanical Products
FITLIFE BRANDS, INC.

Price Impact